Clinical trial
Phase 4 Study of Use of High-dose Intravenous Immune Globulin for Prevent Hyperbilirubinemia Due Rh Hemolytic Disease in Newborns Infants
NCT00288600 is registered in ClinicalTrials.gov with Oswaldo Cruz Foundation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 4 Study of Use of High-dose Intravenous Immune Globulin for Prevent Hyperbilirubinemia Due Rh Hemolytic Disease in Newborns Infants
- Lead sponsor
- Oswaldo Cruz Foundation
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 31, 2006
- Completion date
- August 31, 2010
- Enrollment
- 92 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.